Latest News

Exposure to pesticides and increased risk of AMD
Exposure to pesticides and increased risk of AMD

July 9th 2025

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

A review of the DAVIO 2 phase 2 trial results
A review of the DAVIO 2 phase 2 trial results

July 9th 2025

Health Canada approves aflibercept biosimilar Aflivu
Health Canada approves aflibercept biosimilar Aflivu

July 8th 2025

Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD
Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD

July 8th 2025

Phase 3 PHOENIX trial for oral GA treatment completes enrollment
Phase 3 PHOENIX trial for oral GA treatment completes enrollment

July 8th 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.